Rights in filed and pending U.S. patent applications across the estate, licensed under defined field-of-use, territory, and exclusivity terms.
Licensing
License the architecture, not the implementation.
CIVITERA licenses intellectual property at the layer where governance, autonomy, and accountability are decided. Field of use, territory, and exclusivity are defined within executed agreements; no commercial terms are published.
What is licensed
Four things a counterparty can license.
The architectural layer a counterparty would otherwise have to design, validate, and defend independently.
Technologies subject to pending applications, presented publicly at a non-enabling level of detail.
Extended technical material released to qualified counterparties under appropriate confidentiality arrangements.
Who may engage
Institutions that carry the obligation.
Engagement is open to organisations for whom the governance layer is a structural requirement rather than an optional feature.
Organisations deploying AI-mediated systems who need a defensible architectural position rather than an internal reimplementation.
Platforms subject to converging accountability obligations across multiple jurisdictions.
Public authorities requiring governance infrastructure that can be examined rather than inferred.
National programmes where jurisdictional control and oversight are structural requirements.
Organisations pursuing co-development or joint positions in adjacent technology domains.
Universities and institutes engaging on technical collaboration and evaluation.
Engagement models
Five licensing structures.
Structures are indicative. Actual terms are negotiated bilaterally and reflect counterparty profile, intended deployment, and technology scope.
Sole rights within a defined field of use and territory, for counterparties building a durable market position on the technology.
Parallel rights to deploy the technology where interoperability matters more than exclusivity.
Rights bounded to a defined application domain, allowing several counterparties to operate without overlap.
Co-engineering of next-generation technology with a strategic partner, with future intellectual property shared under negotiated terms.
National or institutional implementation under terms that respect jurisdictional control and oversight obligations.
Enterprise licensingPlatform licensingGovernment and sovereign engagementStrategic partnershipsCo-developmentPilot discussionsControlled technical diligence
Progression
From inquiry to documentation.
A high-level sequence. Not every engagement follows every step, and the order can vary with the nature of the counterparty and the technology.
01
Initial institutional inquiry
A counterparty identifies the technology domain and the nature of the intended engagement.
02
Scope and relevance assessment
CIVITERA assesses which assets are relevant and whether the intended use aligns with the estate.
03
Confidentiality framework where required
Where extended material is needed, appropriate confidentiality arrangements are established in writing.
04
Controlled diligence
Technical material is released to qualified counterparties under those arrangements.
05
Commercial and technical discussion
Field of use, territory, exclusivity, and technical scope are examined together.
06
Transaction-specific documentation
Terms are defined within executed agreements. No commercial terms are published.
Disclosure boundary
What is public, and what is controlled.
The boundary is stated rather than implied. Nothing on the controlled side is published, summarised, or reconstructed on this site.
- Technology positioning, problem domain, and function
- Strategic relevance and implementation contexts
- Patent-pending status and filing office
- The published research position (WP-01)
- Corporate identity and trademark status
- Extended technical briefs for individual technologies
- Non-public filing detail and supporting records
- Investor and estate diligence materials
- Research beyond the published white paper
Publicly available patent records may be independently verified through USPTO systems where applicable. Information concerning non-public applications is provided through controlled verification procedures to qualified counterparties.
Pathways
Where to go from here.
The estate is organised into sector programmes, and engagement differs by counterparty type. Each pathway below treats one of those in depth.
LicensingProgrammes
The sector-to-technology map across the estate.
Read more →
LicensingEnterpriseLicensing context for regulated commercial operators.
Read more →
LicensingGovernmentLicensing context for public authorities and defense counterparties.
Read more →
LicensingPlatformsLicensing context for digital platform operators.
Read more →
LicensingStrategic PartnershipsA possible engagement structure, not a standing programme.
Read more →
GovernmentSocial Media PlatformsDefenseCritical InfrastructureEnterpriseFinancial SectorHealthcareEducation
Engagement
Begin a licensing conversation.
The estate comprises 19 filed/pending U.S. patent applications. Public positioning is available now; extended material proceeds through controlled diligence.